Huntington National Bank’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Huntington National Bank’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Hold	0	–	–	–	1818
2026 Q1	–	Hold	0	–	–	–	1732
2025 Q4	–	Hold	0	–	–	–	1517
2025 Q3	–	Hold	0	–	–	–	1595
2025 Q2	–	Hold	0	–	–	–	1687
2025 Q1	–	Hold	0	–	–	–	1613
2024 Q4	–	Hold	0	–	–	–	1484
2024 Q3	–	Hold	0	–	–	–	1842
2024 Q2	–	Hold	0	–	–	–	1795
2024 Q1	–	Hold	0	–	–	–	1778
2023 Q4	–	Hold	0	–	–	–	2358
2023 Q3	–	Hold	0	–	–	–	2342
2023 Q2	–	Hold	0	–	–	–	2317
2023 Q1	–	Hold	0	–	–	–	2148
2022 Q4	–	Hold	0	–	–	–	2001
2017 Q4	–	Hold	0	–	–	–	1222
2017 Q3	–	Hold	0	–	–	–	1041
2016 Q4	–	Hold	0	–	–	–	1180
2016 Q3	–	Hold	0	–	–	–	1191
2016 Q2	–	Hold	0	–	–	–	1204
2016 Q1	–	Hold	0	–	–	–	1391
2015 Q4	–	Hold	0	–	–	–	1289
2015 Q3	–	Hold	0	–	–	–	1348
2015 Q2	–	Sell	-300	Closed	-$17.5K	–	1165
2015 Q1	$17K	Buy	+300	New	+$16.4K	﹤0.01%	1399
2014 Q4	–	Hold	0	–	–	–	1396
2013 Q4	–	Hold	0	–	–	–	1342
2013 Q3	–	Hold	0	–	–	–	1371
2013 Q2	–	Hold	0	–	–	–	1354

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Huntington National Bank's IHE Position: Q2 2026 in Review

Huntington National Bank held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 0 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

Huntington National Bank first reported a position in IHE in Q1 2015 and has held it in 1 quarter since. The position peaked at $17K in Q1 2015. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Huntington National Bank held 0 shares of iShares US Pharmaceuticals ETF worth $17.6K as of Q2 2026.
Huntington National Bank left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1818 holding.
Huntington National Bank first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and has held it in 1 quarter since.
Huntington National Bank's iShares US Pharmaceuticals ETF position peaked at $17K in Q1 2015.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.